CXCL10 and lung cancer: Analysis of the prognostic information on CXCL10 in cancers (http://kmplot.com/analysis/) revealed a positive correlation of CXCL10 expression with both overall survival (Figure 1A, HR 0.79 [0.67–0.94], logrank P = 0.0078) and relapse free survival (Figure 1B, HR 0.8 [0.65–0.98], logrank P = 0.029) in patients with GC, but not in patients with breast cancer (Figures S1A,D), lung cancer (Figures S1B,E), or ovarian cancer (Figures S1C,F).